Where’s My At-Home Molecular COVID Test?
Elie Dolgin • Jan 24, 2022
Rapid PCR-quality results are possible, but cost and supply issues stand in the way of mass adoption.
Continue reading at IEEE Spectrum.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.